Blog
RSS FeedPosted by Michael Wonder on 05 Oct 2016
Bill Ferris defends R&D reform proposals
5 October 2016 - Fewer than 1% of the 10,000 companies receiving cash refunds as part of the research and development ...
Posted by Michael Wonder on 03 Oct 2016
Obama extends controversial program for rare pediatric drugs
30 September 2016 - Despite objections from his own regulators, President Barack Obama signed into law a bill on Friday ...
Posted by Michael Wonder on 29 Sep 2016
FDA eyes new diabetes outcome measures
29 September 2016 - A recent FDA workshop brought new diabetes outcome measures to the table, focusing on patient-oriented outcome measures. ...
Posted by Michael Wonder on 27 Sep 2016
Innovation in medicine and device development, regulatory review, and use of clinical advances
26 September 2016 - Breakthrough advances in the understanding of fundamental biology and the dawn of an era of precision medicine ...
Posted by Michael Wonder on 26 Sep 2016
EU-US collaboration to boost medicine development for rare diseases
26 September 2016 - The EMA and the U.S. FDA have set up a new ‘cluster’ on rare diseases to share ...
Posted by Michael Wonder on 21 Sep 2016
Evaluating the FDA’s approach to cancer clinical trials
16 September 2016 - Since the announcement of the FDA Oncology Center of Excellence in June 2016 as part of the ...
Posted by Michael Wonder on 20 Sep 2016
The boys who beat the FDA
19 September 2016 - The agency approves a new medicine after an ugly bureaucratic brawl. ...
Posted by Michael Wonder on 19 Sep 2016
FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths
19 September 2016 - Contest seeks to stimulate development of a mobile app to connect those experiencing an overdose with the ...
Posted by Michael Wonder on 14 Sep 2016
SMC introductory industry engagement event - September 2016
13 September 2016 - This event is designed to help pharmaceutical industry members who require an understanding of the processes for ...
Posted by Michael Wonder on 08 Sep 2016
Access to Medicines Working Group communiques
8 September 2016 - The communiques from the February 2015, September 2015 and April 2016 meetings of the Access to Medicines ...
Posted by Michael Wonder on 21 Aug 2016
The impact of innovative pharmaceuticals on New Zealand cancer patients
22 August 2016 - Medicines New Zealand is hosting an educational seminar in Wellington on Wednesday 24 August with University of ...
Posted by Michael Wonder on 19 Aug 2016
“Adaptive pathways” to drug authorisation: adapting to industry?
16 August 2016 - The evidence for benefits of adaptive pathways to patients and public health is lacking or contradictory, ...
Posted by Michael Wonder on 18 Aug 2016
Cancer drug appraisal needs to be reviewed
18 August 2016 - ABPI Executive pens letter to The Guardian. ...
Posted by Michael Wonder on 17 Aug 2016
Proposed new drug guidelines for the PBS put cost-cutting before patients
17 August 2016 - The sustained accessibility of Australians to world-class medicines will be in question if proposed drug review guidelines ...
Posted by Michael Wonder on 17 Aug 2016
German body calls for pause in European plan for fast track drug approval
16 August 2016 - Plans by the European Medicines Agency to expand its fast track approach to approving new drugs have ...